Equities Analysts Set Expectations for JANX Q3 Earnings
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Analysts at HC Wainwright lifted their Q3 2026 EPS estimates for shares of Janux Therapeutics in a report issued on Monday, August 10th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of ($0.45) per share for the quarter, up from their previous […]
12 Aug 10:13 · The Markets Daily